Peripartum Depression, Anxiety and Psychosis: An Outlook on Diagnosis and Management

---

LIVEDHPACCMEOnline via Zoom and Face to Face

Friday, February 3, 2023, 3:45 PM - Saturday, February 4, 2023, 6:30 PM, Weill Cornell Medicine - Qatar and online, Doha, Qatar

Peripartum disorders can vary in prevalence, expression, co-morbidity and presentation of illness. These may be due to psychosocial factors or biological factors. It is important to discuss how to diagnose and manage these illnesses based on current and up to date data. This 2 day activity on peripartum disorders aims to provide an excellent overview for the attendees so that they feel better equipped to evaluate and manage patients presenting with these symptoms.

1. 1- Recognize the risks posed by untreated peripartum psychiatric disorders
2. 2- Demonstrate an understanding on how to identify and evaluate peripartum psychiatric illness
3. 3- Formulate a treatment plan for management of peripartum psychiatric illnesses
4. 4- Describe the intersection between psychosocial factors and peripartum psychiatric illness

QAR 150 or $41

IMPORTANT NOTICE

- The registration closes TWO days before the activity.
- You can register either for the online OR the face-to-face session with NO possible changes.
- Those who register for the ONLINE session will receive a UNIQUE join link on the day of the activity.
- For those who register for the FACE-TO-FACE session, please take note of the building protocols currently followed at Weill Cornell Medicine-Qatar.

REGISTRATION WARNING

Registration for courses managed by Weill Cornell Medicine-Qatar (WCM-Q) can only be completed through WCM-Q's official registration portal. Attendee registrations made through any other sites cannot be honored. WCM-Q is not able to refund fees paid through unaffiliated registration sites, such as eMedEvents.com, MedConfWorld.com, EventEgg.com, and 10times.com.

Please report any unauthorized websites or solicitations for registrations to [email protected].

DHP 

Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Ministry of Public Health's Department of Healthcare Professions.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 5 hours.

ACCME

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to the Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Course Directors: Nasrin Mesaeli, PhD, Zahra Naqvi, MD have no relevant financial relationship to disclose and will not be discussing unlabeled/unapproved use of drugs or products.

Course Faculty: Zahra Naqvi, MD, Nasrin Mesaeli, PhD, Naomi Hynd, DClinPsy, Zainab Imam, MBBS, Suhaila Ghuloum, FRCPsych, Reichert Bernd, MD, Aicha Hind Rifai, MD have no relevant financial relationship to disclose and will not be discussing unlabeled/unapproved use of drugs or products.

Scientific Planning Committee: Phyllis Muffuh Navti, DHSci,  Nicola Lategan, RT, Mark Santos, RN, Christina Vlahos, PhD, Zahra Naqvi, MD, Nasrin Mesaeli, PhD

Administrative Contact: Ameena Abdul Rahim, MSc has no relevant financial relationship to disclose; will not be discussing any unlabeled/unapproved use of drugs or products.

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

Mitigation of Relevant Financial Relationships

Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.